Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe.

Hintersteiner M, Enz A, Frey P, Jaton AL, Kinzy W, Kneuer R, Neumann U, Rudin M, Staufenbiel M, Stoeckli M, Wiederhold KH, Gremlich HU.

Nat Biotechnol. 2005 May;23(5):577-83. Epub 2005 Apr 17.

PMID:
15834405
[PubMed - indexed for MEDLINE]
2.

Bringing amyloid into focus.

Golde TE, Bacskai BJ.

Nat Biotechnol. 2005 May;23(5):552-4. No abstract available.

PMID:
15877070
[PubMed - indexed for MEDLINE]
3.

Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models.

Schmidt A, Pahnke J.

J Alzheimers Dis. 2012;30(3):651-64. doi: 10.3233/JAD-2012-112168.

PMID:
22460331
[PubMed - indexed for MEDLINE]
4.

A novel imaging probe for in vivo detection of neuritic and diffuse amyloid plaques in the brain.

Okamura N, Suemoto T, Shiomitsu T, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Arai H, Sasaki H, Yanai K, Staufenbiel M, Kudo Y, Sawada T.

J Mol Neurosci. 2004;24(2):247-55.

PMID:
15456938
[PubMed - indexed for MEDLINE]
5.

Development of an optical approach for noninvasive imaging of Alzheimer's disease pathology.

Skoch J, Dunn A, Hyman BT, Bacskai BJ.

J Biomed Opt. 2005 Jan-Feb;10(1):11007.

PMID:
15847573
[PubMed - indexed for MEDLINE]
6.

In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265.

Okamura N, Mori M, Furumoto S, Yoshikawa T, Harada R, Ito S, Fujikawa Y, Arai H, Yanai K, Kudo Y.

J Alzheimers Dis. 2011;23(1):37-48. doi: 10.3233/JAD-2010-100270.

PMID:
20930313
[PubMed - indexed for MEDLINE]
7.

In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy.

McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ.

J Neurosci. 2003 Mar 15;23(6):2212-7.

PMID:
12657680
[PubMed - indexed for MEDLINE]
Free Article
8.

Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.

Li Q, Min J, Ahn YH, Namm J, Kim EM, Lui R, Kim HY, Ji Y, Wu H, Wisniewski T, Chang YT.

Chembiochem. 2007 Sep 24;8(14):1679-87.

PMID:
17705341
[PubMed - indexed for MEDLINE]
9.

Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease.

Higuchi M.

Curr Alzheimer Res. 2009 Apr;6(2):137-43.

PMID:
19355848
[PubMed - indexed for MEDLINE]
10.

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.

Bacskai BJ, Hickey GA, Skoch J, Kajdasz ST, Wang Y, Huang GF, Mathis CA, Klunk WE, Hyman BT.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12462-7. Epub 2003 Sep 29.

PMID:
14517353
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology.

Raymond SB, Skoch J, Hills ID, Nesterov EE, Swager TM, Bacskai BJ.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S93-8. doi: 10.1007/s00259-007-0708-7. Review. Erratum in: Eur J Nucl Med Mol Imaging. 2008 May;35(5):1032.

PMID:
18236039
[PubMed - indexed for MEDLINE]
12.

In vivo labeling of amyloid with BF-108.

Suemoto T, Okamura N, Shiomitsu T, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Kudo Y, Sawada T.

Neurosci Res. 2004 Jan;48(1):65-74.

PMID:
14687882
[PubMed - indexed for MEDLINE]
13.

Hybrid FMT-CT imaging of amyloid-beta plaques in a murine Alzheimer's disease model.

Hyde D, de Kleine R, MacLaurin SA, Miller E, Brooks DH, Krucker T, Ntziachristos V.

Neuroimage. 2009 Feb 15;44(4):1304-11. doi: 10.1016/j.neuroimage.2008.10.038. Epub 2008 Nov 7.

PMID:
19041402
[PubMed - indexed for MEDLINE]
14.

High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.

Güntert A, Döbeli H, Bohrmann B.

Neuroscience. 2006 Dec 1;143(2):461-75. Epub 2006 Sep 27.

PMID:
17008022
[PubMed - indexed for MEDLINE]
15.

Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.

Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF.

J Pharmacol Exp Ther. 2007 Aug;322(2):541-9. Epub 2007 May 15.

PMID:
17505020
[PubMed - indexed for MEDLINE]
Free Article
16.

Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology.

Klingner M, Apelt J, Kumar A, Sorger D, Sabri O, Steinbach J, Scheunemann M, Schliebs R.

Int J Dev Neurosci. 2003 Nov;21(7):357-69.

PMID:
14599482
[PubMed - indexed for MEDLINE]
17.

AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.

Johnson AE, Jeppsson F, Sandell J, Wensbo D, Neelissen JA, Juréus A, Ström P, Norman H, Farde L, Svensson SP.

J Neurochem. 2009 Mar;108(5):1177-86. doi: 10.1111/j.1471-4159.2008.05861.x. Epub 2009 Jan 24.

PMID:
19141073
[PubMed - indexed for MEDLINE]
18.

Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.

Noda-Saita K, Yoneyama A, Shitaka Y, Hirai Y, Terai K, Wu J, Takeda T, Hyodo K, Osakabe N, Yamaguchi T, Okada M.

Neuroscience. 2006;138(4):1205-13. Epub 2006 Feb 7.

PMID:
16460878
[PubMed - indexed for MEDLINE]
19.

Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.

Kung MP, Hou C, Zhuang ZP, Skovronsky DM, Zhang B, Gur TL, Trojanowski JQ, Lee VM, Kung HF.

J Mol Neurosci. 2002 Aug-Oct;19(1-2):7-10.

PMID:
12212796
[PubMed - indexed for MEDLINE]
20.

Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.

Ono M, Maya Y, Haratake M, Ito K, Mori H, Nakayama M.

Biochem Biophys Res Commun. 2007 Sep 14;361(1):116-21. Epub 2007 Jul 10.

PMID:
17644062
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk